[1]
L. Hollanda, L. Monteiro, and A. Melo, “Botulinum toxin type A for cephalic cutaneous allodynia in chronic migraine: a randomized, double-blinded, placebo-controlled trial”, NI, vol. 6, no. 4, Dec. 2014.